Question 1

Has Paul Porter received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $7,109 in general payments to Paul Porter across 100 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Paul Porter did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Paul Porter come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Incyte Corporation	6	$4,955
GSK	6	$560
Athenex Pharmaceutical Division, LLC	2	$325
Amgen	17	$320
Johnson & Johnson(2 entities)	10	$197
Novartis	13	$138
Clovis Oncology, Inc.	9	$93
AstraZeneca	5	$75
Pfizer	6	$71
Gilead(2 entities)	5	$70
Merck	4	$62
Lilly USA, LLC	3	$38
Dova Pharmaceuticals	2	$35
Seagen Inc.	2	$31
Genentech USA, Inc.	2	$30
Sanofi	2	$23
Ipsen Biopharmaceuticals, Inc	1	$21
Fortovia Therapeutics, Inc.	2	$20
Exelixis Inc.	1	$18
Beigene USA, Inc.	1	$16
Medtronic	1	$13

Paul Porter

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Other medical oncology in Grosse Pointe Woods